NVO - Novo Nordisk CEO sees Wegovy users sticking with drug: report
2024-01-10 18:02:30 ET
More on Novo Nordisk
- Novo Nordisk A/S (NVO) Presents at J.P. Morgan 42nd Annual Healthcare Conference Transcript
- Profiting From Obesity Drugs HRTS, Novo Nordisk And Eli Lilly
- Novo Nordisk: Latest Insights Confirm Exceptionally Bullish Opportunity
- FDA evaluating reports of GLP-1 drugs and negative side effects
- Study finds Wegovy not associated with suicidal thoughts in users
For further details see:
Novo Nordisk CEO sees Wegovy users sticking with drug: report